ranpirnase
Phase 2- Indications
- Genital warts, Anal dysplasia, Non-small cell lung cancer
Company intelligence / Profile preview
Tamir Biotechnology, Inc.
Monmouth Junction, New Jersey, United Statesglobenewswire.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 2
01
Overview
Ranpirnase demonstrated clear clinical effect in Phase I/II trials targeting genital warts caused by HPV. Over 1,000 patients have been dosed with ranpirnase in cancer/mesothelioma clinical trials, showing strong safety and tolerability profiles. The company's compounds also showed positive antiviral activity against multiple viruses including SARS, Dengue, and outperformed Ganciclovir for Cytomegalovirus in cell culture tests.
- Therapeutic areas
- OphthalmologyOncologyInfectious Diseases
- Modalities
- EnzymesRibonucleases (RNases)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Institute of Allergy and Infectious Diseases (NIAID)
Beyond the preview
Go deeper on Tamir Biotechnology, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tamir Biotechnology, Inc..